US Stock MarketDetailed Quotes

ATOS Atossa Therapeutics

Watchlist
  • 1.2550
  • -0.0450-3.46%
Trading Aug 14 11:28 ET
157.83MMarket Cap-5976P/E (TTM)

Atossa Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Atossa Therapeutics Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.05

+37.50%
Analyst Rating

Strong Buy

Aug 13, 2024

Atossa Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Atossa Therapeutics Earnings Reports

  • Atossa Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 12 09:10 ET

  • Atossa Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 13 09:09 ET

  • Atossa Therapeutics | 10-K: FY2023 Annual Report

    Apr 1 16:09 ET

  • Atossa Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 13, 2023 09:10 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 13, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg